Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
Ayub-Ferreira
S M
SM
Heart Institute (INCOR), University of Sao Paulo Medical School, Sao Paulo, Brazil. silvia.ayub@incor.usp.br
Avila
M S
MS
Feitosa
F S
FS
Souza
G E C
GE
Mangini
S
S
Marcondes-Braga
F G
FG
Issa
V S
VS
Bacal
F
F
Chizzola
P R
PR
Cruz
F D D
FD
Bocchi
E A
EA
D000368:Aged; D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D051437:Renal Insufficiency / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D003404:Creatinine; D020123:Sirolimus